Amylyx Pharmaceuticals Inc AMLX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
2.01quote price arrow down-0.02 (-0.91%)
Volume
29,453
Close
2.03quote price arrow up+0.03 (+1.50%)
Volume
1,441,406
52 week range
1.70 - 30.50
Loading...
  • Open2.05
  • Day High2.13
  • Day Low2.00
  • Prev Close2.00
  • 52 Week High30.50
  • 52 Week High Date05/12/23
  • 52 Week Low1.70
  • 52 Week Low Date04/26/24

Key Stats

  • Market Cap138.052M
  • Shares Out68.01M
  • 10 Day Average Volume2.27M
  • Dividend-
  • Dividend Yield-
  • Beta-0.93
  • YTD % Change-86.21

KEY STATS

  • Open2.05
  • Day High2.13
  • Day Low2.00
  • Prev Close2.00
  • 52 Week High30.50
  • 52 Week High Date05/12/23
  • 52 Week Low1.70
  • 52 Week Low Date04/26/24
  • Market Cap138.052M
  • Shares Out68.01M
  • 10 Day Average Volume2.27M
  • Dividend-
  • Dividend Yield-
  • Beta-0.93
  • YTD % Change-86.21

RATIOS/PROFITABILITY

  • EPS (TTM)0.70
  • P/E (TTM)2.88
  • Fwd P/E (NTM)-1.23
  • EBITDA (TTM)39.89M
  • ROE (TTM)12.73%
  • Revenue (TTM)380.786M
  • Gross Margin (TTM)93.32%
  • Net Margin (TTM)12.94%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Amylyx Pharmaceuticals Inc

 

Profile

MORE
Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate, AMX0035 (sodium phenylbutyrate and taurursodiol, also known as ursodoxicoltaurine) for the treatment of amyotrophic lateral sclerosis (ALS). RELYVRIO (also known as AMX0035), an oral, fixed-dose combination of...
George Milne Ph.D.
Chair of the Board of Directors
James Frates
Chief Financial Officer
Gina Mazzariello
Chief Legal Officer and General Counsel
Address
43 THORNDIKE STREET
Cambridge, MA
02141
United States

Top Peers

SYMBOLLASTCHG%CHG
CHRS
Coherus BioSciences Inc
2.27+0.10+4.61%
ME
23andMe Holding Co.
0.5023-0.0023-0.4558%
PBYI
Puma Biotechnology Inc
4.86-0.10-2.02%
RVNC
Revance Therapeutics Inc
3.95+0.18+4.77%
SGMO
Sangamo Therapeutics Inc
0.5558+0.0338+6.4751%